Andrew D. Ashe - President, Chief Operating Officer and General Counsel at Verve Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Chief Operating Officer and General Counsel
Issuer Symbol
VERV
All Insider Reports
All Insider Reports

Andrew D. Ashe - trading volume in the past year for Verve Therapeutics, Inc.

Holdings reported by Andrew D. Ashe for Verve Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 0 $112,050 $4.15 25 Jul 2025 Direct Common Stock
Common Stock 0 $0 $11.23 25 Jul 2025 Direct
Stock Option (right to buy) 0 25 Jul 2025 Direct Common Stock

Transactions reported by Andrew D. Ashe for Verve Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.